Stryker nominates Quest Diagnostics CEO Jim Davis to board

SYK•2026-11-09

Stryker nominated Quest Diagnostics Chairman, CEO and President Jim Davis for election to its board, effective Jan. 1, 2027.

1. Board nomination

Stryker's board nominated Jim Davis for election as a director on Nov. 9, 2026, with the appointment effective Jan. 1, 2027. Davis is chairman, CEO and president of Quest Diagnostics and has leadership experience in healthcare, medical technology and global operations.

Sources

Stryker nominates Quest Diagnostics CEO Jim Davis to board

Sec

Stryker nominates Quest Diagnostics CEO Jim Davis to board

1. Board nomination

Related News

Diamond Estates extends Bank of Montreal credit facility to June 30, 2027

Grupo Aeroportuario del Pacífico October passenger traffic falls 7% year over year

TechPrecision secures $10 million financing agreement with Rosenthal Capital Group

Sources

Stryker nominates Quest Diagnostics CEO Jim Davis to board

Canada's Equinox Gold Q3 revenue rises on Musselwhite, Camino Rojo production

Lindsay files initial beneficial ownership statement for SVP and CFO Michael J. Koch